Sharron Ladd

Sharron Ladd is a prominent inventor based in Gregory, MI (US), known for his significant contributions to cancer therapy. With a total of seven patents, Ladd has focused on developing innovative methods to enhance the efficacy of cancer treatments.

Latest Patents

Among his latest patents is a method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate. This invention relates to antibodies that bind to the human folate receptor and includes diagnostic assays for folate receptor 1-based therapies. Additionally, he has developed a method for identifying ovarian cancer in subjects likely to respond to anti-folate receptor 1 (FOLR1) antibody. This invention also involves antibodies that bind to the human folate receptor and provides methods for monitoring therapy.

Career Highlights

Sharron Ladd has made remarkable strides in the field of cancer research and therapy. His work has been instrumental in advancing the understanding of folate receptor-targeted treatments, which hold promise for improving patient outcomes.

Collaborations

Some of his notable coworkers include Christina N Carrigan and Olga Ab, who have contributed to the collaborative efforts in his research endeavors.

Conclusion

Sharron Ladd's innovative work in cancer therapy exemplifies the impact of targeted treatments in modern medicine. His patents reflect a commitment to improving therapeutic strategies for cancer patients.

This text is generated by artificial intelligence and may not be accurate.